Cite Filings / TYRA / 0000902664-25-004987

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Tyra Biosciences, Inc. Filed 2025-11-14 Acc 0000902664-25-004987

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-11-17 144 Sale of Securities
2025-11-17 4 Chief Operating Officer sold 131,411 shares at an average $16.04 ($2,108,067)
2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-14 144 Sale of Securities
2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-13 144 Sale of Securities
2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…